Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Uniphyd is a computational drug discovery company that focuses on the critical role of water molecules in molecular recognition and binding. The company's proprietary platform utilizes advanced physics-based algorithms to map "hydration sites" on protein surfaces, providing insights into the thermodynamics of ligand binding. This approach allows for the identification of novel druggable pockets and the optimization of small molecule leads with enhanced potency and selectivity. Uniphyd's technology is designed to address challenging therapeutic targets by leveraging the energetic contributions of water displacement. The company operates primarily as a platform-driven discovery entity, collaborating with partners to advance early-stage drug candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Uniphyd.